CoChat

Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Intramuscular injection of an adeno-associated virus (AAV) vector has resulted in vector dose-dependent, stable expression of canine factor IX (cF.IX) in hemophilia B dogs with an F.IX missense mutation (Herzog et al., Nat. Med. 1999;5:56-63). The use of a species-specific transgene allowed us to study risks and characteristics of antibody formation against the therapeutic transgene product. We analyzed seven dogs that had been injected at a single time point at multiple intramuscular sites with varying vector doses (dose per kilogram, dose per animal, dose per site). Comparison of individual animals suggests an increased likelihood of inhibitory anti-cF.IX (inhibitor) development with increased vector doses, with dose per site showing the strongest correlation with the risk of inhibitor formation. In six of seven animals, such immune responses were either absent or transient, and therefore did not prevent sustained systemic expression of cF.IX. Transient inhibitory/neutralizing anti-cF.IX responses occurred at vector doses of 2 x 10(12)/site, whereas a 6-fold higher dose resulted in a longer lasting, higher titer inhibitor. Anti-cF.IX was efficiently blocked in an eighth animal that was injected with a high vector dose per site, but in addition received transient immune suppression. Inhibitor formation was characterized by synthesis of two IgG subclasses and in vitro proliferation of lymphocytes to cF.IX antigen, indicating a helper T cell-dependent mechanism. Anti-cF.IX formation is likely influenced by the extent of local antigen presentation and may be avoided by limited vector doses or by transient immune modulation.

Overview

Integrity signals

Registry

Crossref · 10.1089/104303402760128513

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 147

Metadata

Authors
Herzog, R. W., Fields, P. A., Arruda, V. R., Brubaker, J. O., Armstrong, E., McClintock, D., Bellinger, D. A., Couto, L. B., Nichols, T. C., & High, K. A.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • HIV Immunopathogenesis Laboratory, Wistar Institute of Biology and Anatomy, Philadelphia, PA 19104
  • University of North Carolina at Chapel Hill (US)
  • Avigen, Alameda, CA 94502
Venue
Human Gene Therapy
Published
2002-07-20
Volume
13
Issue
11
Pages
1281-1291
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W1972852573
Cited by
147
References
33
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 8 · 2016: 2 · 2015: 8 · 2014: 6 · 2013: 4 · 2012: 6
FWCI
5.79
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
Locations
  • Human Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl061921-02)
  • National Heart, Lung, and Blood Institute (R01 HL61921, P01HL064190, R24HL063098)
Topics
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
hemophilia B, factor IX, adeno-associated virus vectors, vector dose, neutralizing antibodies, T cell response, B cell response, T helper cells, IgG subclasses, immunosuppression, canine model
MeSH terms
Dependovirus, Animals, Antibodies, B-Lymphocytes, Cells, Cultured, Hemophilia B, Disease Models, Animal, Dogs, Factor IX, Genetic Vectors, Immunoglobulin G, Injections, Intramuscular, Leukocytes, Mononuclear, Lymphocytes, Mitogens, T-Lymphocytes, Time Factors, Genetic Therapy, Gene Expression, Cytokines, Gene Transfer Techniques, Muscle, Skeletal, Transgenes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy. https://app.cochat.ai/papers/10.1089/104303402760128513
The paper
Herzog, R. W., Fields, P. A., Arruda, V. R., Brubaker, J. O., Armstrong, E., McClintock, D., Bellinger, D. A., Couto, L. B., Nichols, T. C., & High, K. A. (2002). Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy. Human Gene Therapy. https://doi.org/10.1089/104303402760128513

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.